未登录.png)
分享.png)
收藏分享 收藏 G-CSF-producing pulmonary sarcomatoid carcinoma treated with chemoradiotherapy followed by durvalumab: a case reportG-CSF产生型肺肉瘤样癌经化疗放疗后给予durvalumab治疗：一例病例报告
Hashimoto, Naohito; Kaira, Kyoichi; Uno, Tatsuhiko; Hashimoto, Kosuke; Mouri, Atsuto; Yamaguchi, Ou; Imai, Hisao; Shojiguchi, Naoko; Homma, Taku; Kagamu, Hiroshi 分享 收藏 A Case of Combined Small-cell Carcinoma and Adenocarcinoma of the Lung With EGFR Exon 19 Deletion Identified via Liquid Genomic ProfilingFukuda, Yohei; Hashimoto, Kosuke; Kaira, Kyoichi; Mouri, Atsuto; Ishii, Reina; Hashimoto, Naohito; Miura, Yu; Shiono, Ayako; Yamaguchi, Ou; Imai, Hisao; Kagamu, Hiroshi 分享 收藏 Efficacy and Safety of Chemoimmunotherapy in Patients With Advanced Non-small Cell Lung Cancer With Pre-existing Interstitial Pneumonia and Low PD-L1 ExpressionSasada, Aosa; Kawachi, Hayato; Yamada, Tadaaki; Hata, Tae; Goto, Yasuhiro; Amano, Akihiko; Negi, Yoshiki; Watanabe, Satoshi; Furuya, Naoki; Oba, Tomohiro; Ikoma, Tatsuki; Nakao, Akira; Tanimura, Keiko; Taniguchi, Hirokazu; Yoshimura, Akihiro; Fukui, Tomoya; Murata, Daiki; Kaira, Kyoichi; Shiotsu, Shinsuke; Okada, Asuka; Chihara, Yusuke; Kijima, Takashi; Takayama, Koichi 分享 收藏 分享 收藏 分享 收藏 分享 收藏 The impact of antibiotic use on ICI plus chemotherapy versus chemotherapy in NSCLC patients with PD-L1 expression of 1% to 49%PD-L1表达为1%至49%的NSCLC患者中，抗生素使用对ICI联合化疗与化疗的影响Toyota, Y.; Hata, T.; Yamada, T.; Goto, Y.; Kijima, T.; Watanabe, S.; Furuya, N.; Oba, T.; Ikoma, T.; Nakao, A.; Tanimura, K.; Taniguchi, H.; Yoshimura, A.; Fukui, T.; Murata, D.; Kaira, K.; Shiotsu, S.; Hibino, M.; Okada, A.; Takayama, K. 分享 收藏 Phase II trial of atezolizumab plus carboplatin and paclitaxel in patients with metastatic or recurrent thymic carcinoma: Marble studyII期临床试验：阿替利珠单抗联合卡铂和紫杉醇治疗转移性或复发性胸腺癌患者：Marble研究Mimori, T.; Shukuya, T.; Goto, Y.; Asao, T.; Takayama, K.; Kaira, K.; Tanaka, H.; Ko, R.; Tsubata, Y.; Tachihara, M.; Suzuki, T.; Tanizaki, J.; Sugawara, S.; Zenke, Y.; Shirai, Y.; Hayashi, T.; Mori, K.; Takahashi, K. 分享 收藏 Clinical significance of visual cardiac 18F-FDG uptake in advanced non-small cell lung cancerHashimoto, Kosuke; Kaira, Kyoichi; Imai, Hisao; Yamaguchi, Ou; Mouri, Atsuto; Shiono, Ayako; Miura, Yu; Kobayashi, Kunihiko; Kagamu, Hiroshi; Kuji, Ichiei 分享 收藏 Impact of TTF-1 Expression on the Prognostic Prediction of Patients with Non-Small Cell Lung Cancer with PD-L1 Expression Levels of 1%to 49%, Treated with Chemotherapy vs. Chemoimmunotherapy: A Multicenter, Retrospective StudyTTF-1表达对PD-L1表达水平为1%至49%的非小细胞肺癌患者预后预测的影响：化疗与化疗免疫治疗的多中心回顾性研究Nishioka, Naoya; Hata, Tae; Yamada, Tadaaki; Goto, Yasuhiro; Amano, Akihiko; Negi, Yoshiki; Watanabe, Satoshi; Furuya, Naoki; Oba, Tomohiro; Ikoma, Tatsuki; Nakao, Akira; Tanimura, Keiko; Taniguchi, Hirokazu; Yoshimura, Akihiro; Fukui, Tomoya; Murata, Daiki; Kaira, Kyoichi; Shiotsu, Shinsuke; Hibino, Makoto; Okada, Asuka; Chihara, Yusuke; Kawachi, Hayato; Kijima, Takashi; Takayama, Koichi 分享 收藏 Impact of Tumoral β2-Adrenergic Receptor Expression on Chemotherapeutic Response and Prognosis in Patients with Advanced Colorectal CancerKomine, Chika; Sohda, Makoto; Yokobori, Takehiko; Shioi, Ikuma; Ozawa, Naoya; Shibasaki, Yuta; Nakazawa, Nobuhiro; Osone, Katsuya; Shiraishi, Takuya; Okada, Takuhisa; Sano, Akihiko; Sakai, Makoto; Ogawa, Hiroomi; Kaira, Kyoichi; Shirabe, Ken; Saeki, Hiroshi 分享 收藏 ASO Visual Abstract: Impact of Tumoral β2-Adrenergic Receptor Expression on Chemotherapeutic Response and Prognosis in Patients with Advanced Colorectal CancerKomine, Chika; Sohda, Makoto; Yokobori, Takehiko; Shioi, Ikuma; Ozawa, Naoya; Shibasaki, Yuta; Nakazawa, Nobuhiro; Osone, Katsuya; Shiraishi, Takuya; Okada, Takuhisa; Sano, Akihiko; Sakai, Makoto; Ogawa, Hiroomi; Kaira, Kyoichi; Shirabe, Ken; Saeki, Hiroshi 分享 收藏 Prognostic significance of LAT1 expression in pleural mesotheliomaTaguchi, Ryo; Kaira, Kyoichi; Miura, Yu; Umesaki, Tetsuya; Mouri, Atsuto; Imai, Hisao; Kagamu, Hiroshi; Yasuda, Masanori; Kanai, Yoshikatsu; Nitanda, Hiroyuki; Ishida, Hironori; Sakaguchi, Hirozo 分享 收藏 分享 收藏 分享 收藏 A CCR6+Th1-like CD4+T-cell cluster involved in HEV formation predicted lung cancer patients requiring anti-CTLA-4 therapyKagamu, Hiroshi; Yamasaki, Satoshi; Mouri, Atsuhito; Yamaguchi, Ou; Shiono, Ayako; Nishihara, Fuyumi; Miura, Yu; Hashimoto, Kosuke; Imai, Hisao; Kaira, Kyoichi; Koabayashi, Kunihiko; Horimoto, Katsuhisa 分享 收藏 Prospective observational study to explore genes and proteins predicting efficacy and safety of brigatinib for ALK-gene rearranged non-small-cell lung cancer: study protocol for ABRAID study (WJOG11919L)前瞻性观察研究，以探索预测布格替尼对ALK基因重排非小细胞肺癌的疗效和安全性的基因和蛋白质: ABRAID研究的研究方案 (WJOG11919L)Ozawa, Yuichi; Koh, Yasuhiro; Hase, Tetsunari; Chibana, Kenji; Kaira, Kyoichi; Okishio, Kyoichi; Ichihara, Eiki; Murakami, Shuji; Shimokawa, Mototsugu; Yamamoto, Nobuyuki 分享 收藏 Predictive significance of circulating tumor DNA against patients with T790M-positive EGFR-mutant NSCLC receiving osimertinibYamaguchi, Ou; Kasahara, Norimitsu; Soda, Hiroshi; Imai, Hisao; Naruse, Ichiro; Yamaguchi, Hiroyuki; Itai, Miki; Taguchi, Kohei; Uchida, Megumi; Sunaga, Noriaki; Maeno, Toshitaka; Minato, Koichi; Tomono, Hiromi; Ogawara, Daiki; Mukae, Hiroshi; Miura, Yu; Shiono, Ayako; Mouri, Atsuto; Kagamu, Hiroshi; Kaira, Kyoichi 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
